Accel Research Sites Network Acquires Two Florida Clinical Trial Sites
April 20, 2023
Accel Research Sites Network acquired two clinical research site locations in Ormond Beach and Edgewater, Florida (Ormond Medical Arts / OMA Pharmaceutical Research Center and the Edgewater site formerly Complete Health Research), bringing its total sites to 25. The additions expand Accel's reach in Central Florida, add six principal investigators and clinical staff, and broaden the network's therapeutic capabilities across women's health, migraine, dermatology and other indications.
- Buyers
- Accel Research Sites Network
- Targets
- Ormond Medical Arts (OMA) - Pharmaceutical Research Center, Edgewater site (formerly Complete Health Research)
- Platforms
- Accel Research Sites Network
- Industry
- Healthcare Services
- Location
- Florida, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Alcanza Clinical Research Acquires Accel Research Sites Network
July 18, 2023
Healthcare Services
Alcanza Clinical Research has acquired Accel Research Sites Network, a Florida-headquartered multi-specialty clinical research site network with 22 locations across the Southeast U.S. Accel's operations will be integrated into Alcanza's centralized platform while retaining its brand, expanding Alcanza's geographic footprint, therapeutic capabilities, and access to diverse patient populations.
-
Alcanza Clinical Research Acquires Innovation Medical Research Center
April 9, 2024
Healthcare Services
Alcanza Clinical Research, a portfolio company of Martis Capital, has acquired Innovation Medical Research Center, a multi-specialty clinical research site located in Palmetto Bay, Florida. The add-on expands Alcanza’s therapeutic-area capabilities and patient diversity across its investigator site network as part of an ongoing roll-up strategy.
-
Velocity Clinical Research Acquires Omega Medical Research and Buynak Clinical Research
June 16, 2020
Healthcare Services
Durham-based Velocity Clinical Research has acquired Omega Medical Research (Providence, Rhode Island) and Buynak Clinical Research (Valparaiso, Indiana), expanding its multi-site footprint to 12 sites across nine states. The deals, together with a strategic partnership with Elite Research Network, are intended to boost Velocity’s capacity for vaccine and COVID-19 treatment trials while adding geographic and therapeutic diversity.
-
The IMA Group Acquires Accelemed Research Institute
April 11, 2023
Healthcare Services
The IMA Group (IMA Clinical Research) has acquired Accelemed Research Institute, a clinical research site in Austin, Texas, expanding IMA's footprint in the Southwest to more than 20 sites. The acquisition deepens IMA's capabilities in multi-therapeutic clinical trials—particularly cardiometabolic and GI indications—and keeps Accelemed operating under its current name with existing leadership retained.
-
Headlands Research Acquires Eastern Massachusetts Clinical Research Site
April 18, 2023
Healthcare Services
Headlands Research acquired an established clinical research site now operating as Headlands Research Eastern Massachusetts. The site — led by neurologist Dr. Donald Marks and specializing in neurodegenerative diseases such as Alzheimer’s and Parkinson’s — broadens Headlands’ neurology research capabilities and expands its clinical trial site network in Eastern Massachusetts.
-
Velocity Clinical Research Acquires Meridian Clinical Research
December 15, 2022
Healthcare Services
Velocity Clinical Research, a GHO-backed integrated research site organization, has acquired Meridian Clinical Research for an undisclosed amount. The deal creates the largest dedicated clinical research site organization globally (about 80 sites), expands Velocity's U.S. footprint to 25 states and adds Meridian's network of 35+ sites and experienced investigators and staff.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.